![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-feature-radicava-ors-edaravone-real-world-data-at-2024-als-nexus-conference-302190805.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-present-latest-parkinsons-disease-research-at-the-10th-congress-of-the-european-academy-of-neurology-302184636.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-presents-new-results-of-radicava-edaravone-for-people-living-with-als-at-the-european-network-to-cure-als-encals-meeting-2024-302172441.html
https://www.ethypharm.com/wp-content/uploads/2024/06/18-06-24-Press-Release-Argatroban-Ethypharm-Final.pdf
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-highlight-expansive-als-research-at-the-european-network-to-cure-als-encals-2024-meeting-302164847.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-inc-mtpa-stands-with-the-als-community-302153470.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-announces-presentations-at-xxix-world-congress-on-parkinsons-disease-and-related-disorders-302147023.html
https://www.prnewswire.com/news-releases/approximately-usd-10-8-million-invested-in-new-drug-development-for-malaria-and-ntds-in-partners-including-japanese-pharma-shionogi-mitsubishi-tanabe-and-eisai-and-europe-based-institutions-302140073.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-present-radicava-ors-edaravone-real-world-data-at-the-professional-society-for-health-economics-and-outcomes-research-2024-annual-meeting-302133773.html